Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.04.28
2014年度财务决算报告
2015.04.28
关于SPL Acquisition Corp.及其子公司盈利展望实现情形的专项审核报告
2015.04.28
关于美国全资子公司雇主养老金妄想投资的通告
2015.04.28
关于向控股子公司提供委托贷款的通告
2015.04.28
关于举行2014年度报告网上说明会的通告
2015.04.28
关于使用自有资金对Resverlogix Corp.举行投资的通告
2015.04.28
关于公司召募资金年度存放与现实使用情形的鉴证报告
2015.04.28
内部控制审计报告
2015.04.28
2014年度召募资金存放与使用情形的专项报告
2015.04.28
2014年度内部控制评价报告
第一页
上一页
102
103
104
105
106
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】